SMTL ID : 6qty.1

Non-phosphorylated human CLK1 in complex with an indole inhibitor to 1.65 Ang

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

monomer

Ligands

1 x V25: ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate(Non-covalent)

V25.1: 16 residues within 4Å: Chain A: L.20, G.21, E.22, G.23, F.25, V.28, A.42, K.44, F.94, E.95, L.97, E.145, N.146, L.148, V.177, D.178 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.28, A:F.94, A:V.177, A:V.177, A:V.177 Hydrogen bonds: A:N.146 Water bridges: A:N.146, A:D.178

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dekel, N. et al., Expression, purification and crystallization of CLK1 kinase - A potential target for antiviral therapy. Protein Expr.Purif. (2020)

Release Date

2020-03-18

Peptides

Dual specificity protein kinase CLK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity protein kinase CLK1

Related Entries With Identical Sequence